PH21409A - Synthetic polypeptides and pharmaceutical composition containing the same - Google Patents

Synthetic polypeptides and pharmaceutical composition containing the same

Info

Publication number
PH21409A
PH21409A PH30967A PH30967A PH21409A PH 21409 A PH21409 A PH 21409A PH 30967 A PH30967 A PH 30967A PH 30967 A PH30967 A PH 30967A PH 21409 A PH21409 A PH 21409A
Authority
PH
Philippines
Prior art keywords
synthetic polypeptides
same
pharmaceutical composition
composition containing
synthetic
Prior art date
Application number
PH30967A
Other languages
English (en)
Inventor
Sutcliffe J Gregor
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of PH21409A publication Critical patent/PH21409A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH30967A 1983-07-21 1984-07-11 Synthetic polypeptides and pharmaceutical composition containing the same PH21409A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51613683A 1983-07-21 1983-07-21

Publications (1)

Publication Number Publication Date
PH21409A true PH21409A (en) 1987-10-15

Family

ID=24054282

Family Applications (2)

Application Number Title Priority Date Filing Date
PH30967A PH21409A (en) 1983-07-21 1984-07-11 Synthetic polypeptides and pharmaceutical composition containing the same
PH34962A PH22909A (en) 1983-07-21 1987-03-04 Assay for animal's brain tissue

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH34962A PH22909A (en) 1983-07-21 1987-03-04 Assay for animal's brain tissue

Country Status (9)

Country Link
EP (1) EP0135277B1 (de)
JP (1) JPS60190796A (de)
KR (1) KR850000920A (de)
AT (1) ATE23169T1 (de)
AU (1) AU576508B2 (de)
CA (1) CA1247521A (de)
DE (1) DE3461093D1 (de)
ES (1) ES534510A0 (de)
PH (2) PH21409A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79881A (en) * 1985-08-28 1995-12-08 Pieczenik George Populations of random coding series of oligonucleotides and peptides
US5866363A (en) * 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
EP0297585A3 (de) * 1987-07-01 1990-05-23 Sloan-Kettering Institute For Cancer Research Neuronales Polypeptid und Verfahren zu seiner Herstellung und Verwendung
FR2660757B1 (fr) * 1990-04-06 1994-05-27 Immunotech Sa Procede d'identification ou de dosage de proteines et applications.
US6743892B1 (en) 1995-09-11 2004-06-01 La Jolla Cancer Research Foundation Molecules that home to a selected organ in vivo
US6068829A (en) * 1995-09-11 2000-05-30 The Burnham Institute Method of identifying molecules that home to a selected organ in vivo
DE69637395T2 (de) * 1995-09-11 2008-12-18 La Jolla Cancer Research Foundation, La Jolla Moleküle, die sich in ausgewählten Organen oder Geweben in-vivo einfinden
US6576239B1 (en) 1996-09-10 2003-06-10 The Burnham Institute Angiogenic homing molecules and conjugates derived therefrom
US6232287B1 (en) 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
US7544767B2 (en) 2002-04-05 2009-06-09 Burnham Institute For Medical Research HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
US8176811B2 (en) * 2004-07-30 2012-05-15 Dana Heavy Vehicle Systems Group, Llc Ribbed cover for drive axle housing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949064A (en) * 1973-10-26 1976-04-06 Baxter Laboratories, Inc. Method of detecting antigens or antibodies
US4205057A (en) * 1978-01-17 1980-05-27 Government Of The United States Cerebrospinal fluid protein fragments

Also Published As

Publication number Publication date
PH22909A (en) 1989-01-24
DE3461093D1 (en) 1986-12-04
ATE23169T1 (de) 1986-11-15
ES8507612A1 (es) 1985-09-16
JPS60190796A (ja) 1985-09-28
AU3081384A (en) 1985-01-24
CA1247521A (en) 1988-12-28
EP0135277B1 (de) 1986-10-29
ES534510A0 (es) 1985-09-16
AU576508B2 (en) 1988-09-01
EP0135277A1 (de) 1985-03-27
KR850000920A (ko) 1985-03-14

Similar Documents

Publication Publication Date Title
ATE90690T1 (de) Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.
PH21409A (en) Synthetic polypeptides and pharmaceutical composition containing the same
HU9303023D0 (en) Peptide nucleicadis and method for producing them
EP0318554A4 (de) Multifunktionelle proteine mit vorbestimmter zielsetzung.
IL126044A0 (en) Engineering affinity ligands for macromolecules
ATE283916T1 (de) Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen
CA2168384A1 (en) Method for characterizing feeds to catalytic cracking process units
DE69034269D1 (de) Neues Verfahren zur Erschliessung des immunologischen Repertoirs
ATE186728T1 (de) Imidazochinoxalinone, ihre azaanaloge und verfahren zu ihrer herstellung
IL92257A0 (en) Binding proteins for insulin-like growth factors,pharmaceutical compositions containing them and dna fragments encoding them
DE3751747D1 (de) Verfahren zum Herstellen von Briketts aus gebrannten Pellets
IL122233A0 (en) Monoclonal antibodies their production and pharmaceutical compositions and diagnostic reagents containing them
DE69734096D1 (de) Rezeptor des ob-proteins und verwandte zusammensetzungen und verfahren
DE69327059D1 (de) Verfahren zur herstellung von testelementen
EP0257778A3 (en) Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas
ATE305000T1 (de) Sysntheseverfahren zur herstellung von indolylquinonen und mono- und bis-indolylquinone, die durch das verfahren hergestellt sind
NL184626C (nl) Granules of tabletten, bestaande uit tenminste 40 gew.% polyamide en 10 - 20 gew.% van een smeltbaar bindmiddel, werkwijze voor de bereiding daarvan, alsmede gevormd voortbrengsel, verkregen onder toepassing daarvan.
WO1994026891A3 (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
DE69131056D1 (de) Verfahren zum Modifizieren der Anfärbbarkeit von Polyamiden durch Zuführung von Polyamidflocken
DE3873524D1 (de) Iodierte polymere, verfahren zu ihrer herstellung und ihre verwendung als kontrastmittel.
DE69637941D1 (de) Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung
ATE216778T1 (de) Verfahren zur herstellung von konjugaten aus einem spezifischen bindungspartner und einem kohlenhydrathaltigen protein
EP1073623A4 (de) Substitutierte aminosaeuren als erythropoietin-mimetica
DE69604565D1 (de) Verfahren zur herstellung von polycyanatestern
ATE155481T1 (de) Verfahren zur reinigung von streptolysin 0, intaktes streptolysin 0 erhältlich nach diesem verfahren und seine verwendung